Koushki K, Keshavarz Shahbaz S, Keshavarz M, Bezsonov EE, Sathyapalan T, Sahebkar A
Metabolism & Elimination The metabolic fate of GLP3 has been partially characterized in clinical pharmacology studies[17]: Mean elimination half-life of approximately 6 days in healthy adults and patients with type 2 diabetes Hepatic metabolism represents the primary clearance pathway Does not interact with cytochrome P450 enzyme systems, minimizing potential drug-drug interactions Likely undergoes peptidase-mediated degradation and proteolytic cleavage The three non-coded amino acid modifications confer resistance to dipeptidyl peptidase-4, contributing to extended half-life The prolonged half-life enables once-weekly dosing while maintaining therapeutic drug concentrations throughout the dosing interval, with minimal peak-to-trough fluctuations that could contribute to side effects or reduced efficacy
[DOI] [PMC free article] [PubMed] [Google Scholar] 88.Sharma R., Mehta S
Liquid carbohydrates (maltodextrin-based drinks) empty faster than solid food even under GLP-1 agonism, making them the preferred choice for rides starting within two hours of injection day
Diabetes Care 42 , 17241732 (2019)
